ABBV has been in the news 563% more than usual
Jan 08, 2026, 7:31 PM
-1.12%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: AbbVie Inc. (NYSE:ABBV) shares declined after the company denied rumors of acquisition talks and lowered its 2025 financial guidance. This decline followed a period of speculation that had initially boosted shares of Revolution Medicines Inc. (NASDAQ:RVMD) and caused volatility in Erasca Inc. shares.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.